Osteopenia, Osteoporosis Clinical Trial
Official title:
A Double-Blinded Randomized Controlled CER Study of Changes in Bone Mineral Density, Blood Chemistries, Self-Reported Quality of Life and Compliance as a Function of Consuming Micronized Versus Non-micronized Calcium Carbonate
The purpose of this study is to determine whether consuming calcium carbonate that has been micronized is more effective than the traditional form of calcium carbonate in maintaining or increasing bone mineral density in people who are currently taking bisphosphonates or other bone-health medications.
Addressing the need for a form of supplemental calcium that could facilitate increases in BMD without the adverse effects often reported with limestone-based forms of calcium, a patented technology was developed to increase calcium absorbability using both Zet Mill/Ball Mill bottom-up pulverizing technology and 4D top-down ebonite charging technology to create a novel form of calcium referred to as micronized calcium carbonate (MCC). In comparison to other technologies that use water and high heat, which results in a loss of core nutrients and decreased product efficacy, the calcium produced by this unique pulverizing technology is micron-sized (0.03um - 10um) and therefore believed to be more effective. While its tiny size was thought to increase its absorption, the belief was that the intense activation of zinc via the patented ebonite charging process that could maximize the bioavailability of this calcium. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06018467 -
Senolytics to Improve Osteoporosis Therapy
|
Phase 2 | |
Completed |
NCT04122638 -
Prevalence of Sarcopenia and Sarcopenic Obesity in Older Adults
|
||
Completed |
NCT03709381 -
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
|
Early Phase 1 | |
Completed |
NCT03819478 -
Utilizing Protein During Weight Loss to Impact Physical Function and Bone
|
N/A | |
Not yet recruiting |
NCT04719572 -
Intervention Study of Drugs in Patients Osteopenia and Osteoporosis
|
N/A | |
Active, not recruiting |
NCT04708886 -
Romosozumab in Women With Chronic SCI
|
Phase 2 | |
Completed |
NCT03959995 -
Effects of Physical Exercise on Postmenopausal Risk Factors in Women With Osteopenia
|
N/A |